#Novartis Pre-Earnings: Results from Q1 2020 The Pharmaceuticals segment reported 12% growth led by strong Entresto sales fueled by its China launch and increase in new weekly prescriptions in the U.S. This is a great development for the company. #investing #stocks #earnings https://t.co/H8BP0EDob2